Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Materiálatiipa: | Elektrovnnalaš E-girji |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Hamburg, Germany :
Anchor Academic Publishing,
2014.
|
| Fáttát: | |
| Liŋkkat: | An electronic book accessible through the World Wide Web; click to view |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid: Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
- Continuous processing in pharmaceutical manufacturing /
- Biomedical chromatography
- Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
- WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
- The war against counterfeit medicine my story /
- Analytical method validation and instrument performance verification